INSPIRE MEDICAL SYSTEMS, INC. Financials Inspire Medical Systems, Inc.
Equities
INSP
US4577301090
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 237.4 USD | +2.79% |
|
+3.59% | +16.72% |
| 04-19 | RBC Initiates Inspire Medical Systems at Outperform With $285 Price Target | MT |
| 04-18 | Inspire Medical Systems Insider Sold Shares Worth $3,450,450, According to a Recent SEC Filing | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 1,737 | 5,066 | 6,294 | 7,277 | 6,006 | 7,194 | - | - |
| Enterprise Value (EV) 1 | 1,737 | 4,857 | 6,105 | 6,826 | 5,546 | 6,644 | 6,538 | 6,383 |
| P/E ratio | -53 x | -85.9 x | -149 x | -157 x | -283 x | -603 x | 308 x | 125 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 21.2 x | 43.9 x | 27 x | 17.8 x | 9.61 x | 9.2 x | 7.57 x | 6.3 x |
| EV / Revenue | 21.2 x | 42.1 x | 26.2 x | 16.7 x | 8.88 x | 8.49 x | 6.88 x | 5.59 x |
| EV / EBITDA | -61.6 x | -114 x | -158 x | 1,095 x | 123 x | 101 x | 56.3 x | 40.2 x |
| EV / FCF | -48.8 x | -87.5 x | -246 x | 2,760 x | 5,416 x | 110 x | 75.8 x | 51.4 x |
| FCF Yield | -2.05% | -1.14% | -0.41% | 0.04% | 0.02% | 0.91% | 1.32% | 1.94% |
| Price to Book | 12.8 x | 21.3 x | 27.4 x | - | 10.5 x | 10.9 x | 9.17 x | 7.38 x |
| Nbr of stocks (in thousands) | 23,402 | 26,935 | 27,358 | 28,892 | 29,524 | 30,297 | - | - |
| Reference price 2 | 74.21 | 188.1 | 230.1 | 251.9 | 203.4 | 237.4 | 237.4 | 237.4 |
| Announcement Date | 20-02-25 | 21-02-23 | 22-02-08 | 23-02-07 | 24-02-06 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 82.05 | 115.4 | 233.4 | 407.9 | 624.8 | 782.1 | 950.3 | 1,142 |
| EBITDA 1 | -28.2 | -42.55 | -38.63 | 6.236 | 45.04 | 66.07 | 116.1 | 158.9 |
| EBIT 1 | -34.9 | -56.21 | -39.85 | -47.59 | -40.27 | -29.19 | 5.613 | 63.01 |
| Operating Margin | -42.53% | -48.72% | -17.07% | -11.67% | -6.45% | -3.73% | 0.59% | 5.52% |
| Earnings before Tax (EBT) 1 | -33.2 | -57.09 | -41.97 | -44.27 | -19.91 | -6.869 | 27.63 | 54.49 |
| Net income 1 | -33.24 | -57.2 | -42.04 | -44.88 | -21.15 | -9.047 | 24.19 | 67.44 |
| Net margin | -40.52% | -49.58% | -18.01% | -11% | -3.39% | -1.16% | 2.55% | 5.9% |
| EPS 2 | -1.400 | -2.190 | -1.540 | -1.600 | -0.7200 | -0.3936 | 0.7713 | 1.905 |
| Free Cash Flow 1 | -35.58 | -55.5 | -24.79 | 2.473 | 1.024 | 60.6 | 86.3 | 124.1 |
| FCF margin | -43.37% | -48.1% | -10.62% | 0.61% | 0.16% | 7.75% | 9.08% | 10.86% |
| FCF Conversion (EBITDA) | - | - | - | 39.66% | 2.27% | 91.72% | 74.35% | 78.07% |
| FCF Conversion (Net income) | - | - | - | - | - | - | 356.8% | 183.98% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Announcement Date | 20-02-25 | 21-02-23 | 22-02-08 | 23-02-07 | 24-02-06 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 61.68 | 78.4 | 69.38 | 91.39 | 109.2 | 137.9 | 127.9 | 151.1 | 153.3 | 192.5 | 161.1 | 188 | 196.8 | 235.4 | 202.9 |
| EBITDA 1 | -2.65 | -1.477 | -15.7 | -0.931 | -2.092 | 15.24 | -0.68 | 5.627 | 1.895 | 32.96 | -1.415 | 12.44 | 18.66 | 40.47 | 1.844 |
| EBIT 1 | -9.796 | -1.821 | -16.06 | -14.01 | -17.19 | -0.335 | -19.5 | -16.6 | -13.47 | 9.297 | -25.76 | -12.26 | -7.169 | 15.88 | -13.9 |
| Operating Margin | -15.88% | -2.32% | -23.14% | -15.33% | -15.75% | -0.24% | -15.25% | -10.99% | -8.79% | 4.83% | -15.99% | -6.52% | -3.64% | 6.75% | -6.85% |
| Earnings before Tax (EBT) 1 | -10.34 | -2.371 | -16.59 | -14.35 | -16.6 | 3.275 | -15.21 | -11.74 | -8.2 | 15.24 | -19.97 | -6.914 | -0.9652 | 20.92 | -7.974 |
| Net income 1 | -10.35 | -2.391 | -16.69 | -14.49 | -16.85 | 3.15 | -15.42 | -11.95 | -8.54 | 14.76 | -19.71 | -6.772 | -1.148 | 18.51 | -7.54 |
| Net margin | -16.77% | -3.05% | -24.06% | -15.86% | -15.43% | 2.28% | -12.06% | -7.91% | -5.57% | 7.67% | -12.24% | -3.6% | -0.58% | 7.86% | -3.72% |
| EPS 2 | -0.3800 | -0.0900 | -0.6100 | -0.5300 | -0.6000 | 0.1000 | -0.5300 | -0.4100 | -0.2900 | 0.4900 | -0.6747 | -0.2254 | -0.0610 | 0.5772 | -0.2463 |
| Dividend per Share 2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 21-11-02 | 22-02-08 | 22-05-03 | 22-08-02 | 22-11-01 | 23-02-07 | 23-05-02 | 23-08-01 | 23-11-07 | 24-02-06 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | - | 210 | 189 | 451 | 460 | 550 | 656 | 811 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | -35.6 | -55.5 | -24.8 | 2.47 | 1.02 | 60.6 | 86.3 | 124 |
| ROE (net income / shareholders' equity) | -21.9% | -31% | -18.3% | -12.4% | -3.96% | -2.79% | 2.08% | 6.34% |
| ROA (Net income/ Total Assets) | - | -24.7% | -14.6% | -10.4% | -3.41% | -2.35% | 0.2% | 1.9% |
| Assets 1 | - | 231.2 | 288.1 | 430 | 620.9 | 385 | 12,094 | 3,550 |
| Book Value Per Share 2 | 5.800 | 8.810 | 8.400 | - | 19.40 | 21.70 | 25.90 | 32.20 |
| Cash Flow per Share 2 | -1.380 | -2.030 | - | 0.4100 | 0.8400 | 0.8400 | 2.320 | - |
| Capex 1 | 2.74 | 2.46 | 4.67 | 9.1 | 23.6 | 19.7 | 26.6 | 31.3 |
| Capex / Sales | 3.34% | 2.13% | 2% | 2.23% | 3.78% | 2.52% | 2.8% | 2.74% |
| Announcement Date | 20-02-25 | 21-02-23 | 22-02-08 | 23-02-07 | 24-02-06 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
237.4
USD
Average target price
253.8
USD
Spread / Average Target
+6.88%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +16.72% | 7.19B | |
| +12.07% | 128B | |
| -9.04% | 10.65B | |
| +0.91% | 8.82B | |
| +25.15% | 4.99B | |
| +7.17% | 3.4B | |
| -1.36% | 3.03B | |
| -8.73% | 2.14B | |
| -10.15% | 2B | |
| -22.81% | 1.79B |
- Stock Market
- Equities
- INSP Stock
- Financials Inspire Medical Systems, Inc.
